Represented Chicago-based rMark Bio, a company that delivers intelligence solutions to the life science industry, in their acquisition by Within3, a portfolio company of Insight Ventures that is based in Lakewood, Ohio.
Represented in Series A preferred stock financing rounds
Represented Record360 in its sale to Alpine SG
Represented WR Hambrecht + Co. in initial public offering of Truett-Hurst winery (Sonoma, CA), an emerging growth company under the JOBS Act.
Represented Cancer Targeted Technology in exclusive license of lead compound to Advanced Accelerator Applications International.
Represented Integra Ventures, Alliance of Angels, Subdued Excitement and Element8 in connection with fund formations
Represented public companies in connection with PIPE offerings, including Jones Soda, Chemokine Therapeutics and General Moly
Represented Clarisonic in its sale to L’Oreal.
Represented Electrical Geodesics, Inc. in its sale to Phillips.
Initial Public Offering and follow-on public offering for Electrical Geodesics, Inc. and listing on AIM market of London Stock Exchange.
Represented Canadian companies in connection with cross-border financing and merger and acquisition transactions, including Intrawest Corporation, ID Biomedical, Cardiome Pharma, OctigaBay Systems Corp., Abatis Systems Corp., HotHaus Technologies, Challenger Energy Corp., Canadian Superior Energy and Timberwest Forest Holdings.
Represented issuers and underwriters in over 20 initial public offerings and follow-on offerings, including companies such as Electrical Geodesics, Zumiez, Intrawest Corporation (Whistler ski resort), Greenfield Online, Angiotech, Oakley, ID Biomedical, OnHealth and Labor Ready, and underwriters including, WR Hambrecht, Piper Jaffray, Deutsche Bank, RBC and Robertson Stephens.
Represented Elixiter in its sale to Perficient